dc.contributor.author | Tanakol, R | |
dc.contributor.author | Dizdaroglu, F | |
dc.contributor.author | Terzioglu, T | |
dc.contributor.author | Alagol, F | |
dc.contributor.author | Azizlerli, H | |
dc.date.accessioned | 2021-03-05T10:43:28Z | |
dc.date.available | 2021-03-05T10:43:28Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Azizlerli H., Tanakol R., Terzioglu T., Alagol F., Dizdaroglu F., "Steroid cell tumor of the ovary as a rare cause of virilization", MOUNT SINAI JOURNAL OF MEDICINE, cilt.64, ss.130-135, 1997 | |
dc.identifier.issn | 0027-2507 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a49f8cb7-5381-4303-a13e-fda1939e7a2c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/110118 | |
dc.description.abstract | Background: Virilization is associated with either ovarian causes, including polycystic ovary syndrome, hyperthecosis, and ovarian tumor, or with adrenal causes, including tumors and congenital adrenal hyperplasia. In establishing the diagnosis, levels of dehydroepiandresterone sulfate, testosterone, and 17 alpha-hydroxyprogesterone (17-OHP), with their response to dexamethasone treatment, should be assessed; and, where indicated, computerized tomography, ultrasound, and selective venous catheterization should be undertaken. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Steroid cell tumor of the ovary as a rare cause of virilization | |
dc.type | Makale | |
dc.relation.journal | MOUNT SINAI JOURNAL OF MEDICINE | |
dc.contributor.department | , , | |
dc.identifier.volume | 64 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 130 | |
dc.identifier.endpage | 135 | |
dc.contributor.firstauthorID | 118556 | |